{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T10:47:14Z","timestamp":1790246834148,"version":"4.1.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"published-print":{"date-parts":[[2008,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Parathyroid adenoma is the most common cause of primary hyperparathyroidism. Preoperative serum calcium and intact-parathyroid hormone levels are the most useful diagnostic parameters that allow differentiating primary hyperparathyroidism from non-parathyroid-dependent hypercalcemia. Parathyroidectomy is the definitive treatment for primary hyperparathyroidism. Approximately 5% of patients who underwent parathyroidectomy present with persistent or recurrent hyperparathyroidism due to ectopic localization of the adenoma. Functioning oxyphil parathyroid adenoma is an uncommon histological form, seldom causing primary hyperparathyroidism. Parathyroid adenoma with hypercalcemia exhibiting normal parathyroid hormone level is rare. An incidence of 5% to 33% has been documented in the literature; no etiologic explanation has been given. In 1987, parathyroid-hormone-related peptide was isolated as a causative factor of humeral hypercalcemia of malignancy. The presence of parathyroid-hormone-related peptide in parathyroid tissue under normal and pathological conditions has been described in the literature; however, its role in causing hyperparathyroidism has not yet been defined.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Case presentation<\/jats:title>\n            <jats:p>We present a case of persistent hypercalcemia with a normal level of intact-parathyroid hormone due to a substernal parathyroid adenoma, treated with radioguided parathyroidectomy. The final histological diagnosis was oxyphil adenoma, positive for parathyroid-hormone-related peptide antigens.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>In clinical practice, this atypical biochemical presentation of primary hyperparathyroidism should be considered in the differential diagnosis of hypercalcemia. The parathyroid-hormone-related peptide should be considered not only in the presence of malignancy.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1477-7819-6-24","type":"journal-article","created":{"date-parts":[[2008,2,21]],"date-time":"2008-02-21T19:13:47Z","timestamp":1203621227000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Substernal oxyphil parathyroid adenoma producing PTHrP with hypercalcemia and normal PTH level"],"prefix":"10.1186","volume":"6","author":[{"given":"Angela","family":"Gurrado","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Marzullo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Germana","family":"Lissidini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agostino","family":"Lippolis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Rubini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaetano","family":"Lastilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Testini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,2,21]]},"reference":[{"key":"422_CR1","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1053\/j.semnuclmed.2006.03.003","volume":"36","author":"AG Kettle","year":"2006","unstructured":"Kettle AG, O'Doherty MJ: Parathyroid imaging: how good is it and how should it be done?. Semin Nucl Med. 2006, 36: 206-211. 10.1053\/j.semnuclmed.2006.03.003.","journal-title":"Semin Nucl Med"},{"key":"422_CR2","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/1477-7819-2-41","volume":"2","author":"CN Foroulis","year":"2004","unstructured":"Foroulis CN, Rousogiannis S, Lioupis C, Koutarels D, Kassi G, Lioupis A: Ectopic paraesophageal mediastinal parathyroid adenoma, a rare cause of acute pancreatitis. World J Surg Oncol. 2004, 2 (): 41-10.1186\/1477-7819-2-41.","journal-title":"World J Surg Oncol"},{"key":"422_CR3","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1055\/s-2005-836365","volume":"130","author":"S Adamek","year":"2005","unstructured":"Adamek S, Libansky P, Nanka O, Sedy J, Pafko P: Surgical therapy of primaryhyperparathyroidism and it's complications. Experience with 453 patients. Zentralbl Chir. 2005, 130: 109-113. 10.1055\/s-2005-836365.","journal-title":"Zentralbl Chir"},{"key":"422_CR4","volume-title":"Atlas of Tumor Pathology, series 2, fascicle 14","author":"B Castleman","year":"1978","unstructured":"Castleman B, Roth SI: Tumors of the parathyroid glands. Atlas of Tumor Pathology, series 2, fascicle 14. 1978, Washington, DC, Armed Forces Institute of Pathology"},{"key":"422_CR5","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s00268-002-6649-1","volume":"27","author":"A Bergenfelz","year":"2003","unstructured":"Bergenfelz A, Lindblom P, Lindegard B, Valdemarsson S, Westerdahl J: Preoperative normal level of parathyroid hormone signifies an early and mild form of primary hyperparathyroidism. World J Surg. 2003, 27: 481-485. 10.1007\/s00268-002-6649-1.","journal-title":"World J Surg"},{"key":"422_CR6","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1210\/jcem-69-6-1240","volume":"69","author":"K Ikeda","year":"1989","unstructured":"Ikeda K, Arnold A, Mangin M, Kinder B, Vydelingum NA, Brennan MF, Broadus AE: Expression of transcripts encoding a parathyroid hormone-related peptide in abnormal human parathyroid tissues. J Clin Endocrinol Metab. 1989, 69: 1240-1248.","journal-title":"J Clin Endocrinol Metab"},{"key":"422_CR7","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1097\/00000478-198906000-00006","volume":"13","author":"HR Wolpert","year":"1989","unstructured":"Wolpert HR, Vickery AL, Wang CA: Functioning oxyphil cell adenomas of the parathyroid gland. A study of 15 cases. Am J Surg Pathol. 1989, 13: 500-504.","journal-title":"Am J Surg Pathol"},{"key":"422_CR8","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1001\/archotol.132.7.779","volume":"132","author":"BS Bleier","year":"2006","unstructured":"Bleier BS, LiVolsi VA, Chalian AA, Gimotty PA, Botbyl JD, Weber RS: Technetium Tc 99m sestamibi sensitivity in oxyphil cell-dominant parathyroid adenomas. Arch Otolaryngol Head Neck Surg. 2006, 132: 779-782. 10.1001\/archotol.132.7.779.","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"422_CR9","first-page":"179","volume":"17","author":"R Kitazawa","year":"2002","unstructured":"Kitazawa R, Kitazawa S, Maeda S, Kobayashi A: Expression of parathyroid hormone-related protein (PTHrP) in parathyroid tissue under normal and pathological conditions. Histol Histopathol. 2002, 17: 179-184.","journal-title":"Histol Histopathol"},{"key":"422_CR10","first-page":"35","volume":"42","author":"H Matsushita","year":"1992","unstructured":"Matsushita H, Hara M, Nakazawa H, Shishiba Y, Matuhasi T: The presence of immunoreactive parathyroid hormone-related protein in parathyroid adenoma cells. Acta Pathol Jpn. 1992, 42: 35-41.","journal-title":"Acta Pathol Jpn"},{"key":"422_CR11","first-page":"691","volume":"92","author":"DH McGregor","year":"1978","unstructured":"McGregor DH, Lotuaco LG, Rao MS, Chu LLH: Functioning oxyphilic adenoma of parathyroid gland: an ultrastructural and biochemical study. Am J Patol. 1978, 92: 691-712.","journal-title":"Am J Patol"},{"key":"422_CR12","doi-asserted-by":"publisher","first-page":"3826","DOI":"10.1210\/jc.2006-0273","volume":"91","author":"FW Lafferty","year":"2006","unstructured":"Lafferty FW, Hamlin CR, Corrado KR, Arnold A, Shuck JM: Primary hyperparathyroidism with a low-normal, atypical serum parathyroid hormone as shown by discordant immunoassay curves. J Clin Endocrinol Metab. 2006, 91: 3826-3829. 10.1210\/jc.2006-0273.","journal-title":"J Clin Endocrinol Metab"},{"key":"422_CR13","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1097\/00007611-200194030-00013","volume":"94","author":"JB Perez","year":"2001","unstructured":"Perez JB, Pazianos AG: Unusual presentation of primary hyperparathyroidism with osteoporosis, hypercalcemia, and normal parathyroid hormone level. South Med J. 2001, 94: 339-341.","journal-title":"South Med J"},{"key":"422_CR14","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/0002-9343(91)90193-2","volume":"91","author":"AN Hollenberg","year":"1991","unstructured":"Hollenberg AN, Arnold A: Hypercalcemia with low-normal serum intact PTH: a novel presentation of primary hyperparathyroidism. Am J Med. 1991, 91: 547-548. 10.1016\/0002-9343(91)90193-2.","journal-title":"Am J Med"},{"key":"422_CR15","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1111\/j.1464-410X.1976.tb06699.x","volume":"48","author":"JC Hammonds","year":"1976","unstructured":"Hammonds JC, Williams JL, Harvey L: Primary Hyperparathyroidism: a review of cases in the Sheffield area. Br J Urol. 1976, 48: 539-548.","journal-title":"Br J Urol"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1477-7819-6-24.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T01:10:28Z","timestamp":1630458628000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/1477-7819-6-24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2,21]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["422"],"URL":"https:\/\/doi.org\/10.1186\/1477-7819-6-24","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,2,21]]},"assertion":[{"value":"8 December 2007","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2008","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2008","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"24"}}